Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Clinical Neuropharmacology|January 22, 2002
Dyskinesia: L-dopa-induced and tardive dyskinesiaO Rascol, N Fabre
Revue Neurologique|August 1, 2000
[Role of dopaminergic agonists]O Rascol, J L Montastruc
Neurology|April 7, 2010
The delayed-start study in Parkinson disease: can't satisfy everyoneC Warren Olanow, O Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Modafinil and pramipexole-associated somnolenceJ L Montastruc, O Rascol
La Revue Du Praticien|February 1, 1994
[Drug therapy of vertigo]O Rascol, J L Montastruc
Current Opinion in Neurology|September 2, 2000
Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's diseaseJ J Ferreira, O Rascol
Electroencephalography and Clinical Neurophysiology|April 1, 1991
Bereitschaftspotential in a simple movement or in a motor sequence starting with the same simple movementM Simonetta, M Clanet, O Rascol
European Journal of Pharmacology|December 19, 1989
Omega-conotoxin GVIA blocks synaptic transmission in the CA1 field of the hippocampusP Dutar, O Rascol, Y Lamour
Neuro-Chirurgie|January 1, 1997
[Functional imaging]O Rascol, N Fabre, U Sabatini
Experimental Brain Research|January 1, 1989
Rhythmical bursting activity and GABAergic mechanisms in the medial septum of normal and pertussis toxin-pretreated ratsP Dutar, O Rascol, Y Lamour
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Clinical Neuropharmacology|January 22, 2002
Dyskinesia: L-dopa-induced and tardive dyskinesiaO Rascol, N Fabre
Revue Neurologique|August 1, 2000
[Role of dopaminergic agonists]O Rascol, J L Montastruc
Neurology|April 7, 2010
The delayed-start study in Parkinson disease: can't satisfy everyoneC Warren Olanow, O Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Modafinil and pramipexole-associated somnolenceJ L Montastruc, O Rascol
La Revue Du Praticien|February 1, 1994
[Drug therapy of vertigo]O Rascol, J L Montastruc
Current Opinion in Neurology|September 2, 2000
Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's diseaseJ J Ferreira, O Rascol
Electroencephalography and Clinical Neurophysiology|April 1, 1991
Bereitschaftspotential in a simple movement or in a motor sequence starting with the same simple movementM Simonetta, M Clanet, O Rascol
European Journal of Pharmacology|December 19, 1989
Omega-conotoxin GVIA blocks synaptic transmission in the CA1 field of the hippocampusP Dutar, O Rascol, Y Lamour
Neuro-Chirurgie|January 1, 1997
[Functional imaging]O Rascol, N Fabre, U Sabatini
Experimental Brain Research|January 1, 1989
Rhythmical bursting activity and GABAergic mechanisms in the medial septum of normal and pertussis toxin-pretreated ratsP Dutar, O Rascol, Y Lamour
Pageof 22